Chester County News and Community Website
Do you love keeping track of what’s going on in Chester County? Put your knowledge and expertise to use as a MyChesCo community contributor. Learn more >>
MALVERN, PA — Vishay Intertechnology Inc. (NYSE: VSH) expanded its automotive electronics portfolio with four compact common mode chokes designed to reduce power losses and electromagnetic interference as vehicles incorporate …
Vishay Expands Auto Components as Power Demands Rise Read More
KENNETT SQUARE, PA — An 18-year-old Kennett Square man faces assault and harassment charges after police allege he struck another man during a late-night altercation Friday. According to the Kennett …
Kennett Square Altercation Leads to Assault Charge Read More
WASHINGTON, D.C. — The U.S. Mint will begin selling rolls and bags of its 2026 President Donald J. Trump $1 coin on Sept. 2, including a limited number struck in …
U.S. Mint Sets Trump $1 Coin Sale With Rare July 4 Variant Read More
FORT WASHINGTON, PA — Coventry has completed its fourth asset-backed securitization since April 2025, pushing financing through its LILY platform to $1 billion as the Fort Washington company expands institutional …
Coventry’s Life Insurance-Backed Financing Reaches $1 Billion Read More
MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) expects top-line data and regulatory submissions in 2027 from its fully enrolled pivotal Phase 3 Alzheimer’s disease trial, putting its lead drug …
Annovis Sets 2027 Alzheimer’s Readout as Phase 3 Fills Read More
WASHINGTON, D.C. — The U.S. Postal Service plans temporary holiday surcharges on Priority Mail, Priority Mail Express, Ground Advantage and Parcel Select shipments beginning Oct. 4, raising package costs for …
USPS Plans Holiday Package Surcharges Starting Oct. 4 Read More
WASHINGTON, D.C. — Wounded Warrior Project is urging families and communities to identify suicide risks among veterans before they escalate into crises, citing survey data showing more than one-quarter of …
Veteran Suicide Prevention Push Targets Risks Before Crisis Read More
WASHINGTON, D.C. — The Food and Drug Administration approved Priovant Therapeutics Inc.’s Lisraya for adults with dermatomyositis, providing an oral treatment for the rare autoimmune disease after a Phase 3 …
FDA Approves Lisraya as Oral Treatment for Dermatomyositis Read More
PHILADELPHIA, PA — ZeroEyes has deployed its artificial intelligence-based gun detection system across a Kansas public school district using state grant funding, extending the Philadelphia company’s footprint in a school-security …
ZeroEyes Expands School Security Reach With Kansas Deployment Read More
MALVERN, PA — Ocugen Inc. (NASDAQ: OCGN) will present 12-month Phase 2 results for its OCU410 gene therapy in geographic atrophy at a scientific meeting in September, putting new clinical …
Malvern Biotech Ocugen to Present New Eye Gene Therapy Data Read More